Korro Bio (KRRO) Competitors

Prothena (NASDAQ:PRTA) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations.

Do institutionals and insiders believe in PRTA or KRRO?

97.1% of Prothena shares are owned by institutional investors. Comparatively, 13.2% of Korro Bio shares are owned by institutional investors. 9.2% of Prothena shares are owned by insiders. Comparatively, 5.4% of Korro Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Do analysts recommend PRTA or KRRO?

Prothena currently has a consensus price target of $55.00, indicating a potential upside of 547.06%. Korro Bio has a consensus price target of $114.63, indicating a potential upside of 447.66%. Given Prothena's higher possible upside, equities analysts clearly believe Prothena is more favorable than Korro Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prothena	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75
Korro Bio	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Does the MarketBeat Community favor PRTA or KRRO?

Prothena received 583 more outperform votes than Korro Bio when rated by MarketBeat users. However, 100.00% of users gave Korro Bio an outperform vote while only 70.43% of users gave Prothena an outperform vote.

Company	Underperform	Outperform
Prothena	Outperform Votes 612 70.43%	Underperform Votes 257 29.57%
Korro Bio	Outperform Votes 29 100.00%	Underperform Votes No Votes

Does the media refer more to PRTA or KRRO?

In the previous week, Prothena had 1 more articles in the media than Korro Bio. MarketBeat recorded 9 mentions for Prothena and 8 mentions for Korro Bio. Korro Bio's average media sentiment score of 1.00 beat Prothena's score of 0.72 indicating that Korro Bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prothena	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Korro Bio	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PRTA or KRRO more profitable?

Korro Bio has a net margin of 0.00% compared to Prothena's net margin of -90.50%. Prothena's return on equity of -22.67% beat Korro Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prothena	-90.50%	-22.67%	-19.68%
Korro Bio	N/A	-50.25%	-38.48%

Which has more risk & volatility, PRTA or KRRO?

Prothena has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500.

Which has higher earnings and valuation, PRTA or KRRO?

Korro Bio has lower revenue, but higher earnings than Prothena. Prothena is trading at a lower price-to-earnings ratio than Korro Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prothena	$135.16M	3.39	-$147.03M	-$2.30	-3.70
Korro Bio	$2.27M	86.53	-$81.17M	-$9.39	-2.23

Summary

Prothena and Korro Bio tied by winning 9 of the 18 factors compared between the two stocks.